Edition:
United Kingdom

Microbot Medical Inc (MBOT.OQ)

MBOT.OQ on NASDAQ Stock Exchange Capital Market

1.04USD
5:52pm GMT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.04
Open
$1.02
Day's High
$1.04
Day's Low
$1.01
Volume
82,887
Avg. Vol
182,373
52-wk High
$9.94
52-wk Low
$1.00

Chart for

About

Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product... (more)
No analyst recommendations are available for .

Overall

Beta: -0.48
Market Cap(Mil.): $45.59
Shares Outstanding(Mil.): 34.81
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.65 16.44
EPS (TTM): -- -- --
ROI: -- 2.35 10.62
ROE: -- 2.95 14.20

BRIEF-Microbot Medical receives additional government grant for development of its self-cleaning shunt

* Microbot Medical Inc receives additional government grant for development of its self-cleaning shunt Source text for Eikon: Further company coverage:

08 Nov 2017

BRIEF-Microbot Medical Q2 loss per share $0.12

* Microbot Medical Inc reports second quarter 2017 financial results and recent development and strategic progress

14 Aug 2017

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF83.85 +0.30
Pfizer Inc. (PFE.N) $36.69 +0.12
Roche Holding Ltd. (ROG.S) CHF241.60 -0.10
Roche Holding Ltd. (RO.S) CHF243.90 -0.10
Merck & Co., Inc. (MRK.N) $56.68 -0.39
Sanofi SA (SASY.PA) €74.66 -0.37
Abbott Laboratories (ABT.N) $55.19 -0.51
Amgen, Inc. (AMGN.OQ) $177.38 +1.12
Merck KGaA (MRCG.DE) €90.66 -0.50
Biogen Inc (BIIB.OQ) $331.05 +3.31

Earnings vs. Estimates